Given that stem cell therapies target multiple disease mechanisms, we examined the long-term efficacy of NSI-HK532-IGF-1, a human NSC line that we previously characterized in vitro23, in the APP/PS1 AD mouse model. Here, IGF1 is linked to Alzheimer disease.